EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Extramedullary Multiple Myeloma

Zhao Jingliang iD, Qin Xiaoqi iD

European Journal of Haematology · 2026-06 · 116 (6) · 733-743

DOI: 10.1111/ejh.70145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Haematology, online erschienen am 24.02.2026. Verfasst von Zhao Jingliang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Guidance Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extramedullary disease (EMD) of multiple myeloma (MM) is a critical indicator of disease progression, with a complex pathophysiology involving tumor microenvironment dysregulation, chromosomal abnormalities, and aberrant signaling pathway activation. Advances in detection technologies have significantly improved EMD diagnosis rates in recent years, but clinical treatment still faces challenges such as high drug resistance rates and difficulties in managing lesions at specific sites. This article systematically reviews the definition, classification, biological characteristics, pathophysiological mechanisms, diagnostic methods, current treatment strategies, and emerging therapeutic challenges of EMD. It emphasizes the interactions between different pathogenic factors and the heterogeneous therapeutic responses of various EMD subtypes, aiming to provide a comprehensive reference for clinical practice and research directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansTumor MicroenvironmentSignal TransductionDisease ManagementPrognosisMolecular Targeted TherapyCombined Modality Therapy

Stichwörter der Autor:innen

CAR‐Textramedullary diseaseextramedullary plasmacytomamultiple myelomatargeted therapy

Autor:innen und Institutionen

  • Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.

ORCID-Profile: Zhao Jingliang, Qin Xiaoqi

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Guidance Project

Zitieren

APA

Jingliang, Z., & Xiaoqi, Q. (2026). Extramedullary Multiple Myeloma. European Journal of Haematology, 116(6), 733-743. https://doi.org/10.1111/ejh.70145

Vancouver

Jingliang Z, Xiaoqi Q. Extramedullary Multiple Myeloma. European Journal of Haematology. 2026;116(6):733-743. doi:10.1111/ejh.70145

BibTeX
@article{Jingliang2026,
  author = {Jingliang, Zhao and Xiaoqi, Qin},
  title = {Extramedullary Multiple Myeloma},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {116},
  number = {6},
  pages = {733--743},
  doi = {10.1111/ejh.70145}
}
Kostenlos starten →